Yamanouchi Pharmaceuticals Report issue

Contributed to NME For profit Phase 3
Founded: Osaka Japan (1923)
Status: Acquired by Astellas (2005) → now Leo Pharma (2015)

Organization Overview

First Clinical Trial
2002
NCT00151567
First Marketed Drug
2004
solifenacin (vesicare)
First NDA Approval
2004
solifenacin (vesicare)
Last Known Activity
2004

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Yamanouchi